SLC5A2 and hydrops fetalis: SGLT2-Is vs. placebo reduced the risk of HF hospitalisations in White (n = 2 studies) and Black (n = 2 studies), but not in Asian (n = 2 studies) and Other (n = 1 study) populations: HRs (95% CIs) of 0.72 (0.58–0.88), 0.43 (0.21–0.90), 0.70 (0.41–1.22) and 0.31 (0.09–1.09), respectively (Supplementary Appendix 11).